Short Diagnosis-to-Treatment Interval Is Associated With Higher Circulating Tumor DNA Levels in Diffuse Large B-Cell Lymphoma

Maximilian Diehn , Olivier Casasnovas , Stefan Alig , Michel Meignan
Journal of Clinical Oncology

2021
Development and Validation of Biopsy-Free Genotyping for Molecular Subtyping of Diffuse Large B-Cell Lymphoma

Florian Scherer , David M. Kurtz , Aaron M Newman , Mohammad Shahrokh Esfahani
Blood 128 ( 22) 1089 -1089

8
2016
Evaluating upfront high-dose consolidation after R-CHOP for follicular lymphoma by clinical and genetic risk models

Stefan Alig , Vindi Jurinovic , Mohammad Shahrokh Esfahani , Sarah Haebe
Blood Advances 4 ( 18) 4451 -4462

1
2020
Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling

Aadel A. Chaudhuri , Jacob J. Chabon , Alexander F. Lovejoy , Aaron M. Newman
Cancer Discovery 7 ( 12) 1394 -1403

586
2017
Intrinsically Bayesian Robust Kalman Filter: An Innovation Process Approach

Roozbeh Dehghannasiri , Mohammad Shahrokh Esfahani , Edward R. Dougherty
IEEE Transactions on Signal Processing 65 ( 10) 2531 -2546

33
2017
Optimal Bayesian Kalman Filtering With Prior Update

Roozbeh Dehghannasiri , Mohammad Shahrokh Esfahani , Xiaoning Qian , Edward R. Dougherty
IEEE Transactions on Signal Processing 66 ( 8) 1982 -1996

10
2018
Noninvasive Cancer Classification Using Diverse Genomic Features in Circulating Tumor DNA

Mohammad Shahrokh Esfahani , Aaron M. Newman , Florian Scherer , Robert Tibshirani
international conference on bioinformatics 516 -516

2016
Inference of Nonlinear ODE-Based Gene Regulatory Networks via Intrinsically Bayesian Robust Kalman Filtering

Roozbeh Dehghannasiri , Mohammad Shahrokh Esfahani , Edward R. Dougherty
international conference on bioinformatics 542 -543

2016
An experimental design framework for Markovian gene regulatory networks under stationary control policy.

Roozbeh Dehghannasiri , Mohammad Shahrokh Esfahani , Edward R. Dougherty
BMC Systems Biology 12 ( 8) 137

2
2018
Towards Non-Invasive Classification of DLBCL Genetic Subtypes By Ctdna Profiling

Mohammad Shahrokh Esfahani , Stefan Alig , David M. Kurtz , Joanne Soo
Blood 134 551 -551

4
2019
An Atlas of Clinically-Distinct Tumor Cellular Ecosystems in Diffuse Large B Cell Lymphoma

Chloe B. Steen , Bogdan A. Luca , Mohammad Shahrokh Esfahani , Barzin Y. Nabet
Blood 134 655 -655

3
2019
Designing enhanced classifiers using prior process knowledge: Regularized maximum-likelihood

Mohammad Shahrokh Esfahani , Amin Zollanvari , Byung-Jun Yoon , Edward R. Dougherty
2011 IEEE International Workshop on Genomic Signal Processing and Statistics (GENSIPS) 91 -94

2011
Incorporating biological prior knowledge for Bayesian learning via maximal knowledge-driven information priors

Shahin Boluki , Mohammad Shahrokh Esfahani , Xiaoning Qian , Edward R Dougherty
BMC Bioinformatics 18 ( 14) 552 -552

26
2017
Noninvasive detection of clinically relevant copy number alterations in diffuse large B-cell lymphoma.

Michael C. Jin , David Matthew Kurtz , Mohammad Shahrokh Esfahani , Florian Scherer
Journal of Clinical Oncology 35 ( 15_suppl) 7507 -7507

3
2017
Probabilistic reconstruction of the tumor progression process in gene regulatory networks in the presence of uncertainty

Mohammad Shahrokh Esfahani , Byung-Jun Yoon , Edward R Dougherty
BMC Bioinformatics 12 ( 10) 1 -15

14
2011
A mid-chemoradiation dynamic risk model integrating tumor features and ctDNA analysis for lung cancer outcome prediction.

Everett J Moding , Mohammad Shahrokh Esfahani , Barzin Nabet , Yufei Liu
Journal of Clinical Oncology 38 ( 15_suppl) 9046 -9046

2020